For kombineret østrogen- gestagen behandling har adskillige epidemiologiske studier vist en generelt større risiko for brystcancer end ved østrogenbehandling alene.
F or oestrogen plus progestagen combined HRT, several epidemiological studies have reported an overall higher risk for breast cancer than with oestrogens alone.